ENSG00000280371 and epilepsy with myoclonic atonic seizures: SMARCA2 is a chromatin remodeling gene, and mutations in another gene involved in this pathway CHD2 are known to cause MAE, suggesting this pathway as a potential therapeutic target [Carvill et al., 2013].